Отчетность о проведении тестирования

Отчет заполняется старшим рабочей группы по проведению тестирования и подписывается всеми ее членами.

Отчет предоставляется в день проведения тестирования в структуры, уполномоченные для обобщения результатов анализа.

Форма отчета устанавливается в Приложении № 12 (на примере обследования учащихся на предмет злоупотребления алкоголем).

 

 

Список литературы

1. Андреев Е.М., Кирьянов Н.А., Леон Д., Макки М., Томкинс С., Школьников В.М. Злоупотребление алкоголем и преждевременная смертность в России на примере Ижевска. Наркология 2008; 7:38-51

2. Анохина И.П. Биологические механизмы зависимости от психоактивных веществ (патогенез). Лекции по клинической наркологии под редакцией Н.Н. Иванца. М., Российский благотворительный фонд "Нет алкоголизму и наркомании", 1995. С.16-39.

3. Губергриц Н.Б., Лукашевич Г.М., Голубова О.А., Беляева Н.В., Загоренко Ю.А. Панкреатогенный сахарный диабет. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2007 (6):11-16

4. Декларация «Молодежь и алкоголь», Стокгольм, 19-21 февраля 2001 г. – Европейское региональное бюро ВОЗ. Копенгаген. 2001 г.- 6 стр.

5. Демографическая политика России: от размышлений к действию: Редакционная статья // Вестн. Московского тер. общества 2008 (10):3.

6. Европейский план действий по борьбе с потреблением алкоголя на 2000-2005 гг. Всемирная Организация Здравоохранения – 2000 г., 44 с.

7. Егоров В.Ф. О состоянии наркологической службы в России и проблемах её совершенствования. Вопросы наркологии. N 1, 1997. С.10-14.

8. Злоупотребление алкоголем в Российской Федерации: cоциально-экономические последствия и меры противодействия. Доклад Общественной Палаты Российской Федерации. 2009. 84 с.

9. Инструкция пользователя «V8 Operator Manual», Helena Bioscience

10. Инструкция пользователя к набору реагентов «Белковые фракции CDT КАПИЛЛЯРИС (CAPILLARYS CDT)», Sebia

11. Инструкция пользователя к набору реагентов N Latex CDT Kit

12. Инструкция пользователя к набору реагентов Белковые фракции «Белковые фракции CDT МИНИКАП (MINICAP CDT)», Sebia

13. Инструкция пользователя к системе капиллярного электрофореза модельного ряда Capillarys, Sebia

14. Инструкция пользователя к системе капиллярного электрофореза модельного ряда Minicap, Sebia

15. Информационная брошюра ANALIS s.a.: CEofix Application Note 040605 ANALYSIS OF CARBOHYDRATE DEFICIENT TRANSFERRIN using CEofix™ CDT for Beckman Coulter P/ACETM MDQ

16. Информационная брошюра Beckman Coulter: Системы капиллярного электрофореза P/ACE™ MDQ

17. Информационная брошюра Dade Behring: N Latex CDT Assay. Highly Specific CDT Testing: The Convenient Way

18. Информационная брошюра Helena Bioscience Europe: V8 Automated Clinical Capillary Electrophoresis

19. Информационная брошюра Helena Bioscience Europe: V8 E-Class

20. Информационный постер ANALIS s.a.: De l’Escaille F., Brohet M., Pourignaux F. Advantages of Capillary Electrophoresis In the determination of Carbohydrate-deficient Transferrin (CDT).

21. Кошкина Е.А. Проблемы алкоголизма и наркоманий в России на современном этапе. Вопросы наркологии. 1993, N 4. С.66-70.

22. Кошкина Е.А., Шамота А.З., Корчагина Г. А., Вышинский К.В. и др. Методы изучения распространённости потребления психоактивных веществ среди различных групп населения: Пособие для врачей психиатров-наркологов. М., ИЧП агентство Пресса, Оренбург, 1997. 82 с.

23. Леонтьева М.В. Особенности распространения употребления алкоголя подростками и молодежью в образовательной среде // Вопр. наркологии 2007 (1):31–38

24. Лозовой В.В, Кремлева О.В., Лозовая Т.В. Профилактика зависимостей: опыт создания системы первичной профилактики. – М.: ООО «АльянсПринт», 2011. – 450 с.

25. Масленникова Г.Я., Лепехин В.А., Оганов Р.Г. Алкоголизм в Российской Федерации: время принятия решений. Профилактическая медицина. 2012; 2:46-49

26. Межличностное насилие и алкоголь в Российской Федерации. Программа по профилактике насилия и Травматизма. Европейское региональное бюро ВОЗ. 2006. 25 c.

27. Нужный В.П. Механизмы и клинические проявления токсического действия алкоголя: Руководство по наркологии / Под ред. Н.И. Иванца. — М.: Медпрактика, 2002. — Т. 1. — С. 74-94.

28. Павлов А.И., Хазанов А.И. Лабораторная диагностика интоксикации алкоголем у лиц с алкогольной болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2010 (1):44-51

29. Потребление алкоголя и его социальные последствия - забытый аспект. - Европейское региональное бюро ВОЗ. Копенгаген. 2001 г. - 35 стр.

30. Рекламный каталог Bio-Rad: 2010/2011 Clinical HPLC and Toxicology

31. Тарасова О.И., Огурцов П.П., Мазурчик Н.В., Моисеев В.С. Современные лабораторные маркеры употребления алкоголя. КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ И ТЕРАПИЯ 2007; 16(1):1-5

32. Ткач С.М., Сизенко А.К. Естественное течение, диагностика и лечение хронического панкреатита с позиций доказательной медицины. Здоров’я України 2006 (Тематичний номер): 18-21.

33. Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М., 1998. 352 с.

34. Хазанов А.И., Плюснин С.В., С.А. Белякин С.А., Васильев А.П., Бобров А.Н., Павлов А.И, Пехташев С.Г. Хроническая интоксикация алкоголем и заболевания печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2009 (1):43-52

35. Шевченко О.П., Долгов В.В., Олефиренко Г.А. Электрофорез в клинической лаборатории. М.: Реафарм 2006. 160 с.

36. Ягудина Р.И., Куликов А.Ю., Усенко К.Ю. Алкоголизм: затраты государства на лечение и эффект фармакотерапии. Новая аптека 2010. № 3 с. 60-65

37. Alden A., Ohlson S., Pahlsson P., Ryden I. HPLC analysis of carbohydrate deficient transferrin isoforms isolated by the Axis-Shield %CDT method. Clin Chim Acta 2005; 356:143–6.

38. Allen J.P., Litten R.Z., Anton R.F., Cross G.M. Carbohydratedeficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res 1994;18: 799–812.

39. Arndt T. Asialotransferrin – an alternative to carbohydrate-deficient transferrin? Clin Chem 2003;49:1022–1023.

40. Arndt T. Carbohydrate-deficient transferrinasamarkerof chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 2001;47:13–27.

41. Arndt T., Erkens M., Holtkamp K., Keller T., Gressner A.M. High prevalence of increased trisialotransferrin concentrations in patients with anorexia nervosa: Implications for determination of carbohydrate-deficient transferrin. Clinica Chimica Acta 2007; 379:150–153

42. Arndt T., Gierten B., Gussregen B., Werle A., Gruner J. False-positive ethyl glucuronide immunoassay screening associated with chloral hydrate medication as confirmed by LC-MS/MS and self-medication. Forensic Sci.Int. 2009; 187 (1-3)

43. Arndt T., Gressner A., Herwig J., Meier U., Sewell A.C. Argininosuccinate lyase deficiency (ASL) and carbohydrate-deficient transferrin (CDT): Experience with four independent CDT analysis methods — misleading results given by the %CDT TIA assay. Clinica Chimica Acta 2006; 373:117–120

44. Arndt T., Keller T. Forensic analysis of carbohydrate-deficient transferrin (CDT): implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards. Forensic Sci Int 2004; 146:9–16.

45. Arndt T., Korzec A., Bar M., Kropf J. Further arguments against including trisialo-Fe2-transferrin in carbohydrate-deficient transferrin (CDT): a study on male alcoholics and hazardous drinkers. Med Sci Monit 2002; 8:CR411–8.

46. Arndt T., Meier U., Gressner A.M. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferring: experience with four independent CDT analysis methods. Clinica Chimica Acta 2006; 372: 184-187

47. Babor T.F., Higgins-Biddle J.C., Saunders J.B., Monteiro M.G. AUDIT: The Alcohol Use Disorders Identification Test.Guidelines for Use in Primary Care. World Health Organization 2001, 41 p.

48. Baraud J., Schellenberg F., Pagès J-C. Improvement of carbohydrate deficient transferrin measurement by capillary zone electrophoresis using immunosubtraction of immunoglobulins and transferrin. Ann Biol Clin 2009; 67(4): 451-5

49. Bianchi V., Ivaldi A., Raspagni A., Arfini C., Vidali M. Use of Carbohydrate-Deficient Transferrin (CDT) and a Combination of GGT and CDT (GGT–CDT) to Assess Heavy Alcohol Consumption in Traffic Medicine. Alcohol & Alcoholism 2010; 45 (3):247-251

50. Bortolotti F., De Paoli G., Tagliaro F. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001–2005. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 841:96–109.

51. Bortolotti F., Paoli G., Pascali J.P., Tagliaro F. Fully automated analysis of Carbohydrate-Deficient Transferrin (CDT) by using a multicapillary electrophoresis system. Clinica Chimica Acta 2007; 380: 4–7

52. Carchon H.A., Chevigne R., Falmagne J.B., Jaeken J. Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. Clin Chem 2004;50:101–11.

53. Chrostek L., Cylwik B., Gruszewska E., Panasiuk A., Szmitkowski M. N-Latex CDT results in liver diseases. Alcohol and Alcoholism 2012; 1-5

54. Conigrave K.M., Degenhardt L.J., Whitfield J.B., Saunders J.B., Helander A., Tabakoff B. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA Collaborative Project. Alcohol Clin Exp Res 2002; 26: 332–339

55. Conigrave, K. M., Saunders, J. B., & Whitfield, J. B. (1995). Diagnostic tests for alcohol consumption. Alcohol & Alcoholism, 30, 13–26.

56. Consensus statement on the worldwide standardization of the HbA1c measurement. Diabetologia 2007

57. Costantino A., DiGregorio E.J., Korn W., Spayd S., Rieders F. The Effect of the Use of Mouthwash on Ethylglucuronide Concentrations in Urine. Journal of Analytical Toxicology 2006; 30:659-662

58. Delanghe J.R., De Buyzere M.L. Carbohydrate deficient transferrin and forensic medicine. Clinica Chimica Acta (Article in press)

59. Dibbelt L. Does trisialo-transferrin provide valuable information for the laboratory diagnosis of chronically increased alcohol consumption by determination of carbohydrate-deficient transferrin? Clin Chem 2000;46: 1203–5.

60. Emanuele N.V., Swade T.F., Emanuele M. A. Consequences of alcohol use in diabetes. Alcohol health and research world 1998; 22 (2):211-218

61. Feher J., Lengyel G., Szabo G. Carbohydrate-Deficient Transferrin as a Marker of Alcohol Consumption. Hungarian Medical Journal 2007; 1:73-82

62. Flahaut C., Michalski J.C., Danel T., Humbert M.H., Klein A. The effects of ethanol on the glycosylation of human transferrin. Glycobiology 2003;13:191–8.

63. Fleming M. Carbohydrate-Deficient Transferrin: Validity of a New Alcohol Biomarker in a Sample of Patients with Diabetes and Hypertension. JABFP 2004; 17:247-255

64. Fleming M.F., Anton R.F., Spies C.D. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res 2004;28:1347–55.

65. Gonzalo Ph., Pecquet M., Bon Ch., Gonzalo S., Radenne S., Augustin-Normand C., Souquet J-C. Clinical performance of the carbohydrate-deficient transferrin (CDT) assay by the Sebia Capillarys2 system in case of cirrhosis. Interest of the Bio-Rad %CDT by HPLC test and Siemens N-Latex CDT kit as putative confirmatory methods Clinica Chimica Acta (Article in Press)

66. Helander A. Absolute or relative measurement of carbohydrate-deficient transferrin in serum? Experiences with three immunological assays. Clin Chem 1999;45: 131–5.

67. Helander A. Chromatographic measurement of transferring glycoforms for detecting alcohol abuse and congenital disorders of glycosylation. Chromatographic methods in clinical chemistry and toxicology 2007; 87-97

68. Helander A., Bergstro J.P. Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test. Clin Chim Acta 2006;371: 187–90.

69. Helander A., Bergstro J., Freeze H. H. Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms. Clin Chem 2004;50: 954–8.

70. Helander A., Dahl H. Urinary Tract Infection: A Risk Factor for False-Negative Urinary Ethyl Glucuronide but Not Ethyl Sulfate in the Detection of Recent Alcohol Consumption. Clinical Chemistry 2005; 51(9):1728-1730

71. Helander A., Dahl H., Swanson I., Bergstrom J. Evaluation of Dade Behring N Latex CDT: a novel homogenous immunoassay for carbohydrate-deficient transferrin. Alcohol Clin Exp Res 2004;28(Suppl):33A.

72. Helander A., Eriksson G., Stibler H., Jeppsson J-O. Interference of transferrin isoform types with carbohydratedeficient transferrin quantification in the identification of alcohol abuse. Clin Chem 2001;47:1225–33.

73. Helander A., Fors M., Zakrisson B. Study of Axis-Shield new %CDT immunoassay for quantification of carbohydrate-deficient transferrin (CDT) in serum. Alcohol 2001;36:406–12.

74. Helander A., Husa A., Jeppsson J-O. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 2003;49:1881–90.

75. Helander A., Olsson I., Dahl H. Postcollection Synthesis of Ethyl Glucuronide by Bacteria in Urine May Cause False Identification of Alcohol Consumption. Clinical Chemistry 2007; 53(10):1855-1857

76. Helander A., Wielders J.P., Te Stroet R., Bergstrom J.P. Comparison of HPLC and capillary electrophoresis for confirmatory testing of the alcohol misuse marker carbohydrate-deficient transferrin. Clin Chem 2005;51: 1528–31.

77. Hermansson U.,, Knutsson A., Brandt L., Huss A., Runnberg S., Helander A. Screening for high-risk and elevated alcohol consumption in day and shift workers by use of the AUDIT and CDT. Occupational Medicine 2003;53:518–526

78. Hoiseth G., Nordal K., Pettersen E., Morland J. Prolonged urinary detection times of EtG and EtS in patients with decreased renal function. Alcohol Clin Exp Res 2012; 36(7):1148-51

79. Immunonephelometric Carbohydrate-Deficient Transferrin Results and Transferrin Variants. Letters to the Editor. Clinical Chemistry 2013;59 (6): 997–1000

80. Jeppsson J., Arndt T., Schellenberg F., Wielders J., Anton R., Whitfield J., Helander A. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 2007; 45(4): 558–562

81. Jeppsson J-O, Kristensson H., Fimiani C. Carbohydratedeficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin Chem 1993;39: 2115–20.

82. Jeppsson J-O. Isolation and partial characterization of three human transferrin variants. Biochim Biophys Acta 1967;140:468–76.

83. Jeppsson J-O., Arndt T.,Schellenberg F., Wielders J.P.M., Anton R.F., Whitfield J.B., Helander A. Standardization of carbohydrate-deficient transferrin: reply to the letter by Tagliaro and Bortolotti Clin Chem Lab Med 2008;46(5):727–728

84. Jeppsson J-O., Siebelder C., Whitfield J.B., Schellenberg F. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible. Clin Chem Lab Med 2013; 51(5):991–996

85. Jong G., van Dijk J.P., van Eijk H.G. The biology of transferrin. Clin Chim Acta 1990;190:1–46.

86. Keating J., Cheung C., Peters T.J., Sherwood R.A. Carbohydrate deficient transferring in the assessment of alcohol misuse: absolute or relative measurements? A comparison of two methods with regard to total transferring concentration. Clin Chim Acta 1998;272:159–69.

87. Kissack, J. C., Bishop, J., & Leatherwood, A. (2008). Ethylglucuronide as a biomarker for ethanol detection. Pharmacotherapy, 28 (6), 769–781.

88. Kraul D., Hackler R., Althaus H. A novelparticle-enhanced assay for the immunonephelometric determination of carbohydrate-deficient transferrin wabstractx. Alcohol Clin Exp Res 2004;28(Suppl):34A.

89. Landberg E., Pahlsson P., Lundblad A., Arnetorp A., Jeppsson J-O. Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. Biochem Biophys Res Commun 1995; 210:267–74.

90. Lanz C., Thormann W. Capillary zone electrophoresis with a dynamic double coating for analysis of carbohydrate-deficient transferrin in human serum: impact of resolution between disialo-and trisialo transferring on reference limits. Electrophoresis 2003;24:4272–81.

91. Legros F.J., Nuyens V., Minet E., Emonts P., Boudjeltia K.Z., Courbe A., et al. Carbohydrate-deficient transferrin isoforms measured by capillary zone electrophoresis for detection of alcohol abuse. Clin Chem 2002;48:2177–86.

92. Leon D.A., Shlolnikov V.M., McKee M. Alcohol and Russian mortality: a continuing crisis. Addiction 2009; 104:1630-6

93. Litten, R. Z., Bradley, A. M., & Moss, H. B. (2010). Alcohol biomarkers in applied settings: Recent advances and future research opportunities. Alcoholism: Clinical and Experimental Research, 34 (6), 955–967.

94. Maenhout T.M., Baten G., Buyzere M.L., Delanghe J.R. Carbohydrate deficient transferring in a driver’s license regranting program.Alcohol and Alcoholism 2012:1-8

95. Maksic N., Vodnik T., Milovanovic S., Radivojevic L., Obradovic I., Dajak M., Majkic-Singh N. Carbohydrate-deficient transferring – a contemporary biomarker in comparison with traditional laboratory markers of chronic alcohol abuse. JMB 2010; 29:95-101

96. Martensson O., Harlin A., Brandt R., Seppa K., Sillanaukee P. Transferrin isoform distribution: gender and alcohol consumption. Alcohol Clin Exp Res 1997;21:1710–5.

97. McDonald H., Borinskaya S., Kiryanov N., Gil A., Helander A., Leon D. Comparative performance of biomarkers of alcohol consumtion in a population sample of working-aged men in Russia: the Izhevsk family study. Addiction 2013: 1-11

98. Moon H-W., Yun Y-M., Kim S., Choe W.H., Hur M., Kim J.Q. Determination of Carbohydrate-deficient Transferrin Levels by Using Capillary Electrophoresis in a Korean Population. Korean J Lab Med 2010;30:477-84

99. Musshoff F., Albermann E., Madea B. Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods-misleading results? Int J Legal Med 2010; 124(6):623-30

100.Nemtsov A.V. Estimates of total alcohol consumption in Russia, 1980-1994. Drug Alcohol Depend 2000; 58:133-42

101.Niemelä, O. (2007). Biomarkers in alcoholism. Clinica Chimica Acta, 377, 39–49.

102.Panteghini M., John W.G. Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med 2007;45(8):942–944

103.Popova S., Rehm J., Patra J., Zatonski W. Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol 2007; 42:465-73

104.Ramdani B., Nuyens V., Codden T., Perpete G., Colicis J., Lenaerts A., et al. Analyte comigrating with trisialotransferrin during capillary zone electrophoresis of sera from patients with cancer. Clin Chem 2003;49:1854–64.

105.Reisfield G.M., Goldberger B.A., Pesce A.J., Crews B.O.,Wilson G.W. Teitelbaum S.A., Bertholf R.L. Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash. Journal of Analytical Toxicology 2011; 35:264-268

106.Schellenberg F., Girre C., Nalpas B., Plat A., Tome A., Pagès J.C. Analytical evaluation of a new capillary electrophoresis method for carbohydrate-deficient transferrin measurement. Clinica Chimica Acta 2007; 382:48–53

107.Schellenberg F., Mennetrey L., Girre C., Nalpas B., Christophe J. Automated Measurement of Carbohydrate-Deficient Transferrin Using the Bio-Rad %CDT by the HPLC Teston a Variant HPLC System: Evaluation and Comparison with Other Routine Procedures. Alcohol & A lcoholism 2008; 43:569–576.

108.Schellenberg F., Schwan R., Mennetrey L., Loiseaux M.N., Pages J.C., Reynaud M. Dose-effect relation between daily ethanol intake in the range 0–70 grams and %CDT value: validation of a cut-off value. Alcohol 2005;40: 531–4.

109.Schellenberg F., Wielders J.P.M. Evaluation of capillary electrophoresis assay for CDT on SEBIA's Capillarys System: Intra and inter laboratory precision, reference interval and cut-off. Clinica Chimica Acta 2010; 411:1888–1893

110.Schellenberg F.,Benard J.Y., LeGoff A.M., Bourdin C., Weill J. Evaluation of carbohydrate-deficient transferrin compared with Tf index and other markers of alcohol abuse. Alcohol Clin Exp Res 1989;13:605–10.

111.Schwan R., Loiseaux M.N., Albuisson E., Legros F.J., Nuyens V., Malet L., et al. Performance of asialotransferrin in detecting alcohol abuse. Alcohol Clin Exp Res 2005;29:81–3.

112.Schwarz M.J., Domke I., Helander A., Janssens P.M., Van Pelt J., Springer B., et al. Multicentre evaluation of a new assay for determination of carbohydrate-deficient transferrin. Alcohol 2003; 38:270–5.

113.Shield K.D., Rylett M., Gmel G., Kehoe-Chan T.A., Rehm J. Global alcohol exposure estimates by country, territory and region for 2005 – a contribution to the comparative risk assessment for the 2010 Global Burden of disease study. Addiction 2013; 108: 912-22

114.Sorvajarvi K., Blake J.E., Israel Y., Niemela O. Sensitivity and specificity of carbohydrate-deficient transferrin as a marker of alcohol abuse are significantly influenced by alterations in serum transferrin: comparison of two methods. Alcohol Clin Exp Res 1996;20:449–54.

115.Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991;37:2029–37.

116.Stibler H., Allgulander C., Borg S., Kjellin K.G. Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand 1978;204: 49–56.

117.Stibler H., Borg S., Joustra M. A modified method for the assay of carbohydrate-deficient transferrin (CDT) in serum. Alcohol Suppl 1991;1:451–4.

118.Telner A. Alcohol, diabetes and health: a review. Canadian journal of diabetes 2002; 26(3):378-381

119.The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision Spring 2012; 11 (2): 1-8.

120.The Role of Biomarkers in the Treatment of Alcohol Use Disorders. Substance abuse treatment advisory. News for the treatment fields. 2006; 5(4):1-8

121.Turpeinen U., Methuen T., Alfthan H., Laitinen K., Salaspuro M., Stenman U.H. Comparison of HPLC and small column (CDTect) methods for disialotransferrin. Clin Chem 2001;47:1782–7.

122.Use of alcohol and drugs at the workplace. European Foundation for the Improvement of Living and Working Conditions, 2012 (Электронный ресурс: www.eurofound.europa.eu)

123.Wannamethee S.G., Shaper A.G., Perry I.J., Alberti K.G. Alcohol consumption and the incidence of type II diabetes. Epidemiol Community Health 2002; 56:542-548

124.Weykamp C., Wielders J.P.M., Helander A., Anton R.F., Bianchi V.,

125.Wolff F., Mesquita M., Corazza F., Demulder A., Willems D. False positive carbohydrate-deficient transferrin results in chronic hemodialysis patients related to the analytical methodology Clinical Biochemistry (Article in Press)

126.Wolff K., Gross S., Marshall E.J., Keaney F., Sherwood R. The role of carbohydrate deficient transferring as an alternative to gamma glutamyl transferase as a biomarker of continuous drinking: a literature review. Road Safety Research Report No 103.

127.Wurst F.M., Wiesbeck G.A., Metzger J.W., Weinmann W. On sensitivity, specificity and the influence of various parameters on ethyl glucuronide levels in urine-results from the WHO/ISBRA study. Alcohol Clin Exp Res 2004; 28(8):1220-8

128.Wuyts B., Delanghe J.R., Kasvosve I., Gordeuk V.R., Gangaidzo I.T., Gomo Z.A. Carbohydrate-deficient transferrin and chronic alcohol ingestion in subjects with transferrin CD-variants. Clin Chem Lab Med 2001;39:937–43.

 

 

Приложение 1